Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07108101 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Interactions Between Placebo Effects and Mindful Awareness State

StatusNot Yet Recruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 12 months later Jun 1, 2028 → Jun 1, 2029
See other at-risk trials from Trustees of Dartmouth College

Record History

  1. Primary completion pushed from Jun 1, 2028 to Jun 1, 2029 Start date: Jun 1, 2026 to Jun 1, 2027 · Completion pushed from Nov 30, 2028 to Nov 30, 2029 · Eligibility criteria expanded, about 10 words · 1 more Show 4 more changesShow less
    • Start date: Jun 1, 2026 to Jun 1, 2027
    • Completion pushed from Nov 30, 2028 to Nov 30, 2029
    • Eligibility criteria expanded, about 10 words
    • Secondary endpoints: details revised at 1 of 1 entry
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In this experiment,the investigators study the effects of interpersonally induced placebo effects and a mindful awareness induction on negative affect. Specifically, it will be examining the effects of interpersonally induced placebo effects (sham tDCS vs. control) and a mindful awareness induction (mindful state vs. control), as well as their interaction. Each group will undergo fMRI scanning and physiological recording will performing the Multimodal Negative Affect Task (MNAT).
Trial Details
NCT Number NCT07108101
Lead Sponsor Trustees of Dartmouth College
Conditions Placebo Effect, Mindfulness, Pain, Transcranial Direct Current Stimulation (tDCS)
Enrollment 120 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov